Literature DB >> 25517612

Leukocyte migration into inflamed tissues.

Sussan Nourshargh1, Ronen Alon2.   

Abstract

Leukocyte migration through activated venular walls is a fundamental immune response that is prerequisite to the entry of effector cells such as neutrophils, monocytes, and effector T cells to sites of infection, injury, and stress within the interstitium. Stimulation of leukocytes is instrumental in this process with enhanced temporally controlled leukocyte adhesiveness and shape-changes promoting leukocyte attachment to the inner wall of blood vessels under hydrodynamic forces. This initiates polarized motility of leukocytes within and through venular walls and transient barrier disruption facilitated sequentially by stimulated vascular cells, i.e., endothelial cells and their associated pericytes. Perivascular cells such as macrophages and mast cells that act as tissue inflammatory sentinels can also directly and indirectly regulate the exit of leukocytes from the vascular lumen. In this review, we discuss current knowledge and open questions regarding the mechanisms involved in the interactions of different effector leukocytes with peripheral vessels in extralymphoid organs.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25517612     DOI: 10.1016/j.immuni.2014.10.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  368 in total

1.  Different Isoforms of the Neuronal Guidance Molecule Slit2 Directly Cause Chemoattraction or Chemorepulsion of Human Neutrophils.

Authors:  Darrell Pilling; Luis E Chinea; Kristen M Consalvo; Richard H Gomer
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

2.  The Role of Integrin Expressing Cells in Modulating Disease Susceptibility and Progression (January 2016).

Authors:  Aftab A Ansari; Siddappa N Byrareddy
Journal:  Int Trends Immun       Date:  2016-01

Review 3.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 4.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

5.  Leukocyte transcellular diapedesis: Rap1b is in control.

Authors:  Marie-Dominique Filippi
Journal:  Tissue Barriers       Date:  2015-05-21

6.  Targeting of Formyl Peptide Receptor 2 for in vivo imaging of acute vascular inflammation.

Authors:  Tamara Boltersdorf; Junaid Ansari; Elena Y Senchenkova; Jieny Groeper; Denise Pajonczyk; Shantel A Vital; Gaganpreet Kaur; J Steve Alexander; Thomas Vogl; Ursula Rescher; Nicholas J Long; Felicity N E Gavins
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

7.  Pioneer neutrophils release chromatin within in vivo swarms.

Authors:  Graham J Lieschke; Stephen A Renshaw; Philip M Elks; Hannah M Isles; Catherine A Loynes; Sultan Alasmari; Fu Chuen Kon; Katherine M Henry; Anastasia Kadochnikova; Jack Hales; Clare F Muir; Maria-Cristina Keightley; Visakan Kadirkamanathan; Noémie Hamilton
Journal:  Elife       Date:  2021-07-21       Impact factor: 8.140

Review 8.  Extracellular CIRP (eCIRP) and inflammation.

Authors:  Monowar Aziz; Max Brenner; Ping Wang
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

9.  Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature.

Authors:  Naoko Konda; Noritaka Saeki; Shingo Nishino; Kazushige Ogawa
Journal:  Histochem Cell Biol       Date:  2016-09-24       Impact factor: 4.304

10.  Angiogenic and Immunologic Proteins Identified by Deep Proteomic Profiling of Human Retinal and Choroidal Vascular Endothelial Cells: Potential Targets for New Biologic Drugs.

Authors:  Justine R Smith; Larry L David; Binoy Appukuttan; Phillip A Wilmarth
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.